About Us

Senior Director，DMPK

Products Blogs
Fengmin Xi

Fengmin Xi

Mr. Fengmin Xi joined InxMed in March 2023 and currently serves as DMPK Senior Director. Fengmin has more than 10 years of R&D experience in DMPK, toxicology, and medicinal chemistry, additionally, along with rich investment and financing skills in biotechnology. He was previously employed in a biotech boutique investment bank, HollyHigh, and engaged in investment and financing for biotech and CXO companies. Prior to that, he worked for WuXi AppTec (603259. SH/2359.HK) and Medicilon (688202. SH) in clinical bioanalysis, preclinical DMPK, and toxicology. He held a Ph.D. in medicinal chemistry at Peking Union Medical College and Tsinghua University.